77 related articles for article (PubMed ID: 3126026)
21. Cytotoxicity and IL 2 reactivity of cells from rejected or nonrejected allografts.
Dallman MJ; Wood KJ; Morris PJ
Transplant Proc; 1988 Apr; 20(2):226-8. PubMed ID: 3129832
[No Abstract] [Full Text] [Related]
22. Enhancement of rat renal allografts with idiotypic and antiidiotypic monoclonal alloantibodies.
Stuart FP; Fitch FW; McKearn TJ
Transplant Proc; 1982 Jun; 14(2):313-5. PubMed ID: 7051473
[No Abstract] [Full Text] [Related]
23. Synergistic interaction of cyclosporine A with interleukin 2 receptor monoclonal antibody therapy.
Tellides G; Dallman MJ; Morris PJ
Transplant Proc; 1988 Apr; 20(2 Suppl 2):202-6. PubMed ID: 3129840
[No Abstract] [Full Text] [Related]
24. Prolongation of murine cardiac allograft survival by the anti-interleukin-2 receptor monoclonal antibody AMT-13.
Kirkman RL; Barrett LV; Koltun WA; Diamantstein T
Transplant Proc; 1987 Feb; 19(1 Pt 1):618-9. PubMed ID: 3274828
[No Abstract] [Full Text] [Related]
25. Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation.
Depper JM; Leonard WJ; Robb RJ; Waldmann TA; Greene WC
J Immunol; 1983 Aug; 131(2):690-6. PubMed ID: 6408186
[TBL] [Abstract][Full Text] [Related]
26. Anti-interleukin 2 monoclonal antibody following simultaneous pancreatic and kidney transplantation: a randomized trial vs rabbit antithymocyte globulin.
Cantarovich D; Hourmant M; Dantal J; Baatard R; Le Mauff B; Jacques Y; Paineau J; Murat A; Soulillou JP
Transplant Proc; 1993 Feb; 25(1 Pt 2):1366. PubMed ID: 8442143
[No Abstract] [Full Text] [Related]
27. [Use of OKT3 monoclonal antibodies and anti-TAC for the quantitative evaluation of interleukin-2].
Cornaglia-Ferraris P; Baffico M
Boll Ist Sieroter Milan; 1985; 64(6):471-4. PubMed ID: 3938289
[TBL] [Abstract][Full Text] [Related]
28. Immunologic monitoring of monoclonal antibody therapy: comparison of five antibodies as immunosuppressants of renal allograft rejection.
Cosimi AB; Colvin RB; Jaffers GJ; Giorgi JV; Delmonico FL; Fuller TC; Russell PS
Transplant Proc; 1984 Dec; 16(6):1459-61. PubMed ID: 6390847
[No Abstract] [Full Text] [Related]
29. Characterization of the anti-CD4-induced permanent acceptance of rat renal allografts.
Lehmann M; Kuttler B; Siegling A; Gordalla A; Riedel H; Lacha J; Hahn HJ; Brock J; Volk HD
Transplant Proc; 1993 Oct; 25(5):2859-60. PubMed ID: 8212264
[No Abstract] [Full Text] [Related]
30. Diagnostic and therapeutic applications of monoclonal antibodies to human T-cell subsets in renal transplant recipients.
Cosimi AB
Urol Clin North Am; 1983 May; 10(2):289-99. PubMed ID: 6344388
[No Abstract] [Full Text] [Related]
31. Effect of monoclonal anti-IL-2 antibodies on the survival of rat cardiac allografts.
Sakagami K; Ohnishi T; Matsuoka J; Ohsaki T; Higaki K; Hanzawa Y; Hamuro J; Orita K
Transplant Proc; 1987 Feb; 19(1 Pt 1):586-90. PubMed ID: 3547830
[No Abstract] [Full Text] [Related]
32. Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.
Tsoukas CD; Landgraf B; Bentin J; Valentine M; Lotz M; Vaughan JH; Carson DA
J Immunol; 1985 Sep; 135(3):1719-23. PubMed ID: 3926881
[TBL] [Abstract][Full Text] [Related]
33. Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trial.
van Gelder T; Zietse R; Yzermans JN; Rischen-Vos J; Vaessen LM; Weimar W
Transplant Proc; 1996 Dec; 28(6):3221-2. PubMed ID: 8962247
[No Abstract] [Full Text] [Related]
34. Multiple cannulation of the primate superficial lateral coccygeal vein.
Stickrod G; Pruett DK
Lab Anim Sci; 1979 Jun; 29(3):398-9. PubMed ID: 116074
[TBL] [Abstract][Full Text] [Related]
35. Production of lymphokines by circulating human T lymphocytes that express or lack receptors for interleukin 2.
Palacios R
J Immunol; 1984 Apr; 132(4):1833-6. PubMed ID: 6321592
[TBL] [Abstract][Full Text] [Related]
36. Preclinical evaluation of immunosuppression selective for T cells recognizing class I histocompatibility antigens.
Wright JK; Barrett LV; Delmonico FL; Fuller TC; Cosimi AB
Transplant Proc; 1987 Feb; 19(1 Pt 2):1106-9. PubMed ID: 3547852
[No Abstract] [Full Text] [Related]
37. Effect of LFA-1 inhibition on immediate organ function in concordant ex-vivo hemoperfusion of primate kidneys.
Storck M; Reichel S; Techt B; Sirsjö A; Krombach F; Hammer C; Abendroth D
Transplant Proc; 1996 Apr; 28(2):765-6. PubMed ID: 8623391
[No Abstract] [Full Text] [Related]
38. Prophylactic use of the anti-IL-2 receptor monoclonal antibody LO-Tact-1 in cadaveric renal transplantation: results of a randomized study.
Kriaa F; Hiesse C; Alard P; Lantz O; Noury J; Charpentier B; Bazin H
Transplant Proc; 1993 Feb; 25(1 Pt 1):817-9. PubMed ID: 8438496
[No Abstract] [Full Text] [Related]
39. Immunohistochemical localization of cells reacting with monoclonal antibodies directed against the interleukin-2 receptor of murine, rat and human origin.
Takacs L; Osawa H; Törö I; Diamantstein T
Clin Exp Immunol; 1985 Jan; 59(1):37-44. PubMed ID: 3918819
[TBL] [Abstract][Full Text] [Related]
40. Anti-CD25 monoclonal antibody modulates cytokine expression and prolongs allografts survival in rats cardiac transplantation.
Xia J; Jiang X; Huang Y; Zhang K; Xiao S; Yang C
Chin Med J (Engl); 2003 Mar; 116(3):432-5. PubMed ID: 12781053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
